Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Recurso digital |
| Langue: | |
| Publié: |
Zenodo
2025
|
| Sujets: | |
| Accès en ligne: | https://doi.org/10.5281/zenodo.14861648 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Table des matières:
- <div>The goal of this project is to investigate whether we can use host-directed therapy (ruxolitinib) in conjunction with the anti-malarial drug artemether-lumefantrine to enhance immune responses in malaria-naïve individuals participating in a controlled human malaria infection model with P. falciparum-induced blood-stage malaria.</div> <div>With support from the Gates Foundation’s Collaboratory, we have generated immunoassay data on samples collected from study participants, as well as supernatants obtained from in vitro experiments.</div>